A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity

Clinical trial NCT06680440 · COMPLETED

Trial details

NCT number: NCT06680440
Sponsor: Ascletis Pharma (China) Co., Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Weight Management

Start date: 2024-08-26
Primary completion: 2025-04-03
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.